Uramit MB Drug Interactions
Currently displaying 15 drugs known to have a minor interaction with Uramit MB (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate).
- 257 major drug interactions
- 487 moderate drug interactions
- 15 minor drug interactions
Minor interactions with Uramit MB (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
Note: Showing generic names only.
Uramit MB alcohol/food interactions
There are 3 alcohol/food interactions with Uramit MB (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate).
Uramit MB disease interactions
There are 37 disease interactions with Uramit MB (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate) which include:
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- reactive airway diseases
- myasthenia gravis
- infectious diarrhea
- inflammatory bowel disease
- intestinal obstruction disorders
- crystalluria
- gout
- liver disease
- methemoglobinemia in G-6-PD
- hypocalcemia
- phosphate imbalance
- GI toxicity
- renal dysfunction
- Reye's syndrome
- electrolyte imbalance
- cardiac disease
- tachycardia
- coronary artery disease
- gastric ulcer
- gastroesophageal reflux
- ulcerative colitis
- liver disease
- renal failure
- renal dysfunction
- anemia
- coagulation
- dialysis
- G-6-PD deficiency
- hepatotoxicity
- hypertension
- hyperthyroidism
- diarrhea
- fever
More about Uramit MB (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Uramit MB consumer information
- Check interactions
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- Drug class: urinary antispasmodics
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.